Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia

JAMA Dermatology - United States
doi 10.1001/jamadermatol.2015.36
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Adverse Event Reporting in Surgical Trials and Early Phase Studies: The Need for New and Joint Perspectives

British Medical Journal
Medicine
2017English

Pharmacy Student Perceptions of Adverse Event Reporting

American Journal of Pharmaceutical Education
PharmacologyPharmacyMedicineToxicologyEducationPharmaceutics
2011English

Seasonal and Geographic Variation in Adverse Event Reporting

Drugs - Real World Outcomes
Pharmacology
2016English

Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials

Mayo Clinic Proceedings: Innovations, Quality & Outcomes
2019English

Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?

Drug Safety
ToxicologyPharmacology
2019English

Three-Component Mixture Model-Based Adverse Drug Event Signal Detection for the Adverse Event Reporting System

CPT: Pharmacometrics and Systems Pharmacology
ModelingSimulationCardiovascular MedicinePharmacologyCardiology
2018English

Monitoring Adverse Social and Medical Events in Public Health Trials: Assessing Predictors and Interpretation Against a Proposed Model of Adverse Event Reporting

Trials
MedicinePharmacology
2019English

A Tolerability Burden Index in Schizophrenia: Incorporating Patient Perspective in Clinical Trial Adverse Event Reporting

Journal of Market Access & Health Policy
2017English

Reporting of Clinical Trials in Gut: The CONSORT Statement. Consolidated Standards of Reporting Trials.

Gut
Gastroenterology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy